Lisa Giovannelli

Dr. Lisa Giovannelli

Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Section Pharmacology and Toxicology, University of Florence, Viale G.B. Pieraccini, 6, 50139 Firenze, Italy
orcid

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2008 in Mutagenesis
Verified
Journal Article
Open access
PDF file
ACAndrew Collins
Andrew Collins
Amaya AzquetaAmaya Azqueta
Amaya Azqueta
GBGunnar Brunborg
Gunnar Brunborg
Isabel GaivãoIsabel Gaivão
Isabel Gaivão
Lisa GiovannelliLisa Giovannelli
Lisa Giovannelli
RŠRudolf Štětina
Rudolf Štětina
The comet assay is a versatile and sensitive method for measuring single- and double-strand breaks in DNA. The mechanism of formation of comets (under neutral or alkaline conditions) is best understood by analogy with nucleoids, in which relaxation of DNA supercoiling in a structural loop of DNA by a single DNA break releases that loop to extend into a halo—or, in the case of the comet assay, to be pulled towards the anode under the electrophoretic field. A consideration of the simple physics underlying electrophoresis leads to a better understanding of the assay. The sensitivity of the assay is only fully appreciated when it is calibrated: between one hundred and several thousand breaks per cell can be determined. By including lesion-specific enzymes in the assay, its range and sensitivity are greatly increased, but it is important to bear in mind that their specificity is not absolute. Different approaches to quantitation of the comet assay are discussed. Arguments are presented against trying to apply the comet assay to the study of apoptosis. Finally, some of the advantages and disadvantages of using the comet assay on lymphocyte samples collected in human studies are rehearsed.

1 December 2005 in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Verified
Journal Article
Closed access
PDPiero Dolara
Piero Dolara
Cristina LuceriCristina Luceri
Cristina Luceri
Carlotta De FilippoCarlotta De Filippo
Carlotta De Filippo
AFAngelo Pietro Femia
Angelo Pietro Femia
Lisa GiovannelliLisa Giovannelli
Lisa Giovannelli
ACAlberto Cresci
Alberto Cresci

1 June 1995 in Neuroscience
Verified
Journal Article
Closed access
Lisa GiovannelliLisa Giovannelli
Lisa Giovannelli
FCF. Casamenti
F. Casamenti
CSC. Scali
C. Scali
LBL. Bartolini
L. Bartolini
GPG. Pepeu
G. Pepeu

1 April 2006 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
SSSimonetta Salvini
Simonetta Salvini
FSFrancesco Sera
Francesco Sera
DCDonatella Caruso
Donatella Caruso
Lisa GiovannelliLisa Giovannelli
Lisa Giovannelli
Francesco VisioliFrancesco Visioli
Francesco Visioli
DPDomenico PALLI
Domenico PALLI
Extra-virgin olive oils (EVOO), high in phenolic compounds with antioxidant properties, could be partly responsible for the lower mortality and incidence of cancer and CVD in the Mediterranean region. The present study aims to measure oxidative DNA damage in healthy human subjects consuming olive oils with different concentrations of natural phenols. A randomised cross-over trial of high-phenol EVOO (high-EVOO; 592mg total phenols/kg)Vlow-phenol EVOO (low-EVOO; 147mg/kg) was conducted in ten postmenopausal women in Florence. Subjects were asked to substitute all types of fat and oils habitually consumed with the study oil (50g/d) for 8 weeks in each period. Oxidative DNA damage was measured by the comet assay in peripheral blood lymphocytes, collected at each visit during the study period. Urine samples over 24h were collected to measure the excretion of the olive oil phenols. The average of the four measurements of oxidative DNA damage during treatment with high-EVOO was 30% lower than the average during the low-EVOO treatment (p=0·02). Urinary excretion of hydroxytyrosol and its metabolite homovanillyl alcohol were significantly increased in subjects consuming high-EVOO. Despite the small sample size, the present study showed a reduction of DNA damage by consumption of an EVOO rich in phenols, particularly hydroxytyrosol.

1 December 2011 in Molecular Pharmacology
Verified
Journal Article
Open access
PDF file
MPMaria Pittelli
Maria Pittelli
RFRoberta Felici
Roberta Felici
VPVanessa Pitozzi
Vanessa Pitozzi
Lisa GiovannelliLisa Giovannelli
Lisa Giovannelli
Elisabetta BigagliElisabetta Bigagli
Elisabetta Bigagli
ACAlberto Chiarugi
Alberto Chiarugi
During the last several years, evidence that various enzymes hydrolyze NAD into bioactive products prompted scientists to revisit or design strategies able to increase intracellular availability of the dinucleotide. However, plasma membrane permeability to NAD and the mitochondrial origin of the dinucleotide still wait to be clearly defined. Here, we report that intracellular NAD contents increased upon exposure of cell lines or primary cultures to exogenous NAD (eNAD). NAD precursors could not reproduce the effects of eNAD, and they were not found in the incubating medium containing eNAD, thereby suggesting direct cellular eNAD uptake. We found that in mitochondria of cells exposed to eNAD, NAD and NADH as well as oxygen consumption and ATP production were increased. Conversely, DNA repair, a well known NAD-dependent process, was unaltered upon eNAD exposure. We also report that eNAD conferred significant cytoprotection from apoptosis triggered by staurosporine, C2-ceramide, or N-methyl-N′-nitro-N-nitrosoguanidine. In particular, eNAD reduced staurosporine-induced loss of mitochondrial membrane potential and ensuing caspase activation. Of importance, pharmacological inhibition or silencing of the NAD-dependent enzyme SIRT1 abrogated the ability of eNAD to provide protection from staurosporine, having no effect on eNAD-dependent protection from C2-ceramide or N-methyl-N′-nitro-N-nitrosoguanidine. Taken together, our findings, on the one hand, strengthen the hypothesis that eNAD crosses the plasma membrane intact and, on the other hand, provide evidence that increased NAD contents significantly affects mitochondrial bioenergetics and sensitivity to apoptosis.

1 July 1999 in Neuroscience
Verified
Journal Article
Closed access
FCF. Casamenti
F. Casamenti
CPC. Prosperi
C. Prosperi
CSC. Scali
C. Scali
Lisa GiovannelliLisa Giovannelli
Lisa Giovannelli
MCM.A. Colivicchi
M.A. Colivicchi
GPG. Pepeu
G. Pepeu